AI Verdict
INGN has stronger fundamentals based on our AI analysis.
INO vs INGN Fundamental Comparison
| Metric | INO | INGN |
|---|---|---|
| Revenue | $65,343.0 | $348.7M |
| Net Income | $-84.9M | $-22.7M |
| Net Margin | -130,000.0% | -6.5% |
| ROE | -352.5% | -11.8% |
| ROA | -114.3% | -7.6% |
| Current Ratio | 1.40x | 3.12x |
| Debt/Equity | 2.60x | 0.00x |
| EPS | $-1.81 | $-0.86 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
INO vs INGN: Frequently Asked Questions
Is INO or INGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), INGN has stronger fundamentals. INO is rated STRONG SELL (92% confidence) while INGN is rated SELL (85% confidence). This is not investment advice.
How does INO compare to INGN fundamentally?
INOVIO PHARMACEUTICALS, INC. has ROE of -352.5% vs Inogen Inc's -11.8%. Net margins are -130,000.0% vs -6.5% respectively.
Which stock pays higher dividends, INO or INGN?
INO has a dividend yield of N/A or no dividend while INGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in INO or INGN for long term?
For long-term investing, consider that INO has STRONG SELL rating with 92% confidence, while INGN has SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about INO vs INGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For INO vs INGN, the AI consensus favors INGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.